Rossari Historical Cash Flow
| ROSSARI Stock | 796.95 3.50 0.44% |
Analysis of Rossari Biotech cash flow over time is an excellent tool to project Rossari Biotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 589.9 M or Net Income of 991.1 M as it is a great indicator of Rossari Biotech ability to facilitate future growth, repay debt on time or pay out dividends.
Rossari |
About Rossari Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Rossari balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Rossari's non-liquid assets can be easily converted into cash.
Rossari Biotech Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most accounts from Rossari Biotech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. As of now, Rossari Biotech's End Period Cash Flow is increasing as compared to previous years. The Rossari Biotech's current Other Cashflows From Investing Activities is estimated to increase to about 480.9 M, while Change To Inventory is forecasted to increase to (891.6 M).
Rossari Biotech cash flow statement Correlations
Click cells to compare fundamentals
Rossari Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rossari Biotech cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (37.7M) | (320.3M) | (481.9M) | 7.3M | (938.5M) | (891.6M) | |
| Investments | (1.2B) | 195.3M | 799.6M | (1.8B) | (1.0B) | (980.5M) | |
| Change In Cash | 234.7M | (140.0M) | 222.7M | 323.6M | (440.3M) | (418.3M) | |
| Net Borrowings | (164.2M) | 628.9M | (610.1M) | (48.1M) | (43.3M) | (45.5M) | |
| Free Cash Flow | (211.4M) | (103.2M) | (88.7M) | 1.2B | (880.3M) | (836.3M) | |
| Change In Working Capital | (310.7M) | (483.1M) | (1.1B) | (272.0M) | (1.6B) | (1.5B) | |
| Begin Period Cash Flow | 57.4M | 292.1M | 152.1M | 374.8M | 692.0M | 726.6M | |
| Total Cashflows From Investing Activities | (364.2M) | (1.9B) | (371.8M) | (3.0B) | (2.7B) | (2.6B) | |
| Other Cashflows From Financing Activities | 1.6B | 2M | 2.9B | 594.0M | (168.0M) | (159.6M) | |
| Depreciation | 168.5M | 228.3M | 480.6M | 629.3M | 603.9M | 320.2M | |
| Other Non Cash Items | 20.1M | (12.7M) | 85.9M | 197.9M | 81.1M | 53.1M | |
| Dividends Paid | 105.9M | 26.5M | 25.4M | 27.5M | (27.6M) | (26.2M) | |
| Capital Expenditures | 759.7M | 580.8M | 382.3M | 328.8M | 1.3B | 1.4B | |
| Total Cash From Operating Activities | 548.3M | 477.7M | 293.6M | 1.5B | 432.6M | 589.9M | |
| Change To Account Receivables | (204.1M) | (404.5M) | (425.3M) | (279.7M) | (1.1B) | (1.1B) | |
| Net Income | 880.6M | 1.1B | 1.4B | 1.4B | 1.3B | 991.1M | |
| Total Cash From Financing Activities | 1.6B | (245.9M) | 2.9B | 608.6M | 161.9M | 153.8M | |
| End Period Cash Flow | 292.1M | 152.1M | 374.8M | 698.3M | 251.7M | 254.9M | |
| Other Cashflows From Investing Activities | 15.0M | 35.3M | 49.7M | (494.9M) | 458.0M | 480.9M | |
| Change To Netincome | 18.4M | 57.9M | (69.8M) | (33.8M) | (30.4M) | (28.9M) | |
| Change To Liabilities | 672.2M | (69.0M) | 241.7M | (222.8M) | (200.5M) | (190.5M) | |
| Sale Purchase Of Stock | (975.8M) | (309.5M) | (3.0B) | (655.0M) | (589.5M) | (619.0M) | |
| Issuance Of Capital Stock | 1B | 426.5M | 3.0B | 42.1M | 38.5M | 36.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rossari Stock
The Cash Flow Statement is a financial statement that shows how changes in Rossari balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Rossari's non-liquid assets can be easily converted into cash.